Literature DB >> 12005126

The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure: the Wittenoom data.

Alan Rogers, Gershom Major.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12005126     DOI: 10.1093/annhyg/mef002

Source DB:  PubMed          Journal:  Ann Occup Hyg        ISSN: 0003-4878


× No keyword cloud information.
  6 in total

1.  The effect of asbestosis on lung cancer risk beyond the dose related effect of asbestos alone.

Authors:  A Reid; N de Klerk; G L Ambrosini; N Olsen; S C Pang; G Berry; A W Musk
Journal:  Occup Environ Med       Date:  2005-12       Impact factor: 4.402

Review 2.  Role of mutagenicity in asbestos fiber-induced carcinogenicity and other diseases.

Authors:  Sarah X L Huang; Marie-Claude Jaurand; David W Kamp; John Whysner; Tom K Hei
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2011       Impact factor: 6.393

3.  The additional risk of malignant mesothelioma in former workers and residents of Wittenoom with benign pleural disease or asbestosis.

Authors:  A Reid; N de Klerk; G Ambrosini; N Olsen; S C Pang; A W Musk
Journal:  Occup Environ Med       Date:  2005-10       Impact factor: 4.402

4.  Malignant pleural and peritoneal mesotheliomas in former miners and millers of crocidolite at Wittenoom, Western Australia.

Authors:  G Berry; N H de Klerk; A Reid; G L Ambrosini; L Fritschi; N J Olsen; E Merler; A W Musk
Journal:  Occup Environ Med       Date:  2004-04       Impact factor: 4.402

Review 5.  Applying definitions of "asbestos" to environmental and "low-dose" exposure levels and health effects, particularly malignant mesothelioma.

Authors:  B W Case; J L Abraham; G Meeker; F D Pooley; K E Pinkerton
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2011       Impact factor: 6.393

6.  Malignant mesotheliomas in former miners and millers of crocidolite at Wittenoom (Western Australia) after more than 50 years follow-up.

Authors:  G Berry; A Reid; P Aboagye-Sarfo; N H de Klerk; N J Olsen; E Merler; P Franklin; A W Musk
Journal:  Br J Cancer       Date:  2012-02-07       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.